~0 spots leftby May 2025

Quitbot Program for Smoking Cessation

Recruiting in Palo Alto (17 mi)
Jonathan Bricker, Ph.D. - Psychotherapy ...
Overseen byJonathan B Bricker
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Fred Hutchinson Cancer Research Center
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data

Trial Summary

What is the purpose of this trial?

This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.

Research Team

Jonathan Bricker, Ph.D. - Psychotherapy ...

Jonathan B Bricker

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Eligibility Criteria

This trial is for smokers who have smoked at least one cigarette daily for the past year, want to quit within a month, and are willing to try a digital program. They must live in the US, read English, not use other cessation methods, be open to random assignment to either program, and have daily access to a smartphone with text messaging and Facebook Messenger.

Inclusion Criteria

Has at least daily access to their own smartphone
Not using other smoking cessation interventions (This eligibility requirement helps ensure results are due to the treatments we recommend rather than those that participants are doing on their own.)
I am 18 years old or older.
See 8 more

Exclusion Criteria

I do not meet the specific requirements listed for the trial.

Treatment Details

Interventions

  • Control Smoking Cessation Program (Behavioural Intervention)
  • Experimental Smoking Cessation Program (Behavioural Intervention)
  • QuitBot Smoking Cessation Program (Behavioural Intervention)
  • Texting Smoking Cessation Program (Behavioural Intervention)
Trial OverviewThe study compares two remote digital smoking cessation programs. Participants will receive support through their smartphones using either an experimental or control program designed to help them stop smoking.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (QuitBot Experimental)Experimental Treatment1 Intervention
Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.
Group II: Group II (QuitBot Control)Active Control1 Intervention
Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Fred Hutch/University of Washington Cancer ConsortiumSeattle, WA
Loading ...

Who Is Running the Clinical Trial?

Fred Hutchinson Cancer Research Center

Lead Sponsor

Trials
444
Recruited
148,000+
Dr. Nancy Davidson profile image

Dr. Nancy Davidson

Fred Hutchinson Cancer Research Center

Chief Medical Officer since 2020

MD from Harvard Medical School

Dr. Thomas J. Lynch Jr. profile image

Dr. Thomas J. Lynch Jr.

Fred Hutchinson Cancer Research Center

Chief Executive Officer since 2020

MD from Yale University, BA from Yale College

Fred Hutchinson Cancer Center

Lead Sponsor

Trials
583
Recruited
1,341,000+
Dr. W. Thomas Purcell profile image

Dr. W. Thomas Purcell

Fred Hutchinson Cancer Center

Chief Medical Officer since 2022

MD from Emory University School of Medicine, MBA from University of Chicago

Dr. Thomas J. Lynch Jr. profile image

Dr. Thomas J. Lynch Jr.

Fred Hutchinson Cancer Center

Chief Executive Officer since 2020

MD from Yale School of Medicine

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Dr. Douglas R. Lowy profile image

Dr. Douglas R. Lowy

National Cancer Institute (NCI)

Chief Executive Officer since 2023

MD from New York University School of Medicine

Dr. Monica Bertagnolli profile image

Dr. Monica Bertagnolli

National Cancer Institute (NCI)

Chief Medical Officer since 2022

MD from Harvard Medical School